Logistics & Transportation

Articles

Duplicate rebates have resulted in revenue leakage for manufacturers.

The Impact of 340B on Commercial Contracts

As a result, time to treatment for the brand Gilead product is expected to increase from 16 to 14 days.

FDA Approves Updated Manufacturing Turnaround Time for Gilead’s CAR T-Cell Therapy

The pharmaceutical packaging company unveils a new siliconization line at its SQLM plant in France.

SGD Pharma Grows Siliconized Glass Vial Capacity

The latest financial commitment adds 24,000 liters of biologics drug substance-capacity to the company’s network.  

AbbVie Invests an Additional $223 Million in Singapore Manufacturing Plant

The Identification of Medicinal Product framework seeks to establish a common language for identifying, documenting, and exchanging information about medicinal products.

Challenges and Benefits of Implementing IDMP in the Pharmaceutical Industry

Acquisition is expected to strengthen company’s CDMO business, while establishing a footprint in the generics space.

Bora Pharmaceuticals Completes $210 Million Purchase of Upsher-Smith 

Roots Analysis report suggests increase can be attributed to the growing demand for advanced therapies and biologics.

Report: Pharmaceutical Contract Manufacturing Market Expected to Hit $140 Billion by 2030

Manufacturers should leverage the knowledge base of personnel working in sterility assurance and in microbiology laboratories. 

Challenges in Cell and Gene Therapy Manufacturing, Sterility Assurance

Review article explores the latest developments surrounding expression and purification strategies. 

Advances in Plant-Made Vaccine Technology

In the midst of being approved for commercial manufacturing of Pluvict, the 70,000 square-foot site was built specifically to accommodate RLT production. 

Manufacturing & Packaging